Abstract Previously we described an involvement of the C-type lectin receptor CD94 and the neuronal adhesion molecule CD56 in the interaction of natural killer (NK) cells with Hsp70-protein and Hsp70-peptide TKD. Therefore, differences in the cell surface density of these NK cell-specific markers were investigated comparatively in CD94-sorted, primary NK cells and in established NK cell lines NK-92, NKL, and YT after TKD stimulation. Initially, all NK cell types were positive for CD94; the CD56 expression varied. After stimulation with TKD, the mean fluorescence intensity (mfi) of CD94 and CD56 was upregulated selectively in primary NK cells but not in NK cell lines. Other cell surface markers including natural cytotoxicity receptors remained unaffected in all cell types. CD3-enriched T cells neither expressing CD94 nor CD56 served as a negative control. High receptor densities of CD94/CD56 were associated with an increased cytolytic response against Hsp70 membrane-positive tumor target cells. The major histocompatibility complex (MHC) class I-negative, Hsp70-positive target cell line K562 was efficiently lysed by primary NK cells and to a lower extent by NK lines NK-92 and NKL. YT and CD3-positive T cells were unable to kill K562 cells. MHC class-I and Hsp70-positive, Cxϩ tumor target cells were efficiently lysed only by CD94-sorted, TKD-stimulated NK cells with high CD94/CD56 mfi values. Hsp70-specificity was demonstrated by antibody blocking assays, comparative phenotyping of the tumor target cells, and by correlating the amount of membrane-bound Hsp70 with the sensitivity to lysis. Remarkably, a 14-mer peptide (LKD), exhibiting only 1 amino acid exchange at position 1 (T to L), neither stimulated Hsp70-reactivity nor resulted in an upregulated CD94 expression on primary NK cells. Taken together our findings indicate that an MHC class I-independent, Hsp70 reactivity could be associated with elevated cell surface densities of CD94 and CD56 after TKD stimulation.
INTRODUCTION
Natural killer (NK) cells are large granular lymphocytes comprising 5% to 20% of the peripheral blood mononuclear cells (PBMNCs) (Trinchieri 1989) . In contrast to T cells, NK cells do neither express the multimolecular CD3 complex nor ␣/␤ and ␥/␦ T cell receptors. Almost all NK cells are positive for the neuronal adhesion molecule CD56, mediating homo-and heterophilic cell adhesion regulated by killer cell receptors, which are known to interact with self-major histocompatibility complex (MHC) class-I or class I-like molecules (Lanier 1998a , Borrego et al 2002 . According to the missing-self theory, NK cells preferentially recognize and kill virus-infected or transformed cells with reduced, lost, or altered self-MHC class-I molecule expression (Ljunggren and Kärre 1990) . In humans, 3 distinct killer cell receptor families have been identified (Lanier 1998a) : killer cell immunoglobulin (Ig) receptors (KIRs), Ig-like transcripts (ILTs), and C-type lectin receptors. The KIRs are characterized by 2 or 3 extracellular localized Ig-like domains recognizing MHC class-I alleles including HLA-A, HLA-B, and HLA-C (Moretta et al 1993; Wagtmann et al 1995; Pende et al 1996) . Depending on their cytoplasmic domain containing an immunoreceptor tyrosine-based inhibition motif or an immunoreceptor tyrosine-based activating motif, NK cells mediate inhibitory and activating signals (Colonna and Samaridis 1995; Biassoni et al 1996) . ILTs also belong to the Ig-like superfamily (Colonna et al 1997; Cosman et al 1997) . They are inhibitory receptors expressed predominantly on myeloid cells, dendritic cells, and B cells (Colonna et al 1997) . ILT-2, which is expressed on some NK cells interacts directly with a broad spectrum of classical and nonclassical HLA molecules including HLA-G (Navarro et al 1999) . Most C-type lectin receptors are heterodimers consisting of CD94 covalently bound to members of the NKG2 family (Lanier et al 1994; Lazetic et al 1996) . These receptors interact with nonclassical HLA-E molecules, presenting leader peptides derived from HLA-A, HLA-B, HLA-C, and HLA-G (Borrego et al 1998; Braud et al 1998; Lee et al 1998) . CD94/ NKG2A is an inhibitory receptor, whereas CD94/ NKG2C, CD94/NKG2E, and CD94/NKG2F are activating receptors (Brooks et al 1997; Lanier 1998b) . The activating receptor NKG2D also belongs to the C-type lectin family, but in contrast to other members it forms homodimers . NKG2D is constitutively expressed on NK cells, ␥/␦ T cells, and CD8ϩ T cells and interacts with the MHC class I chain-related (MIC) antigens, MICA and MICB, and the UL16-binding proteins, which are induced by stress or neoplastic transformation Cosman et al 2001) . Recently, a new group of activatory receptors, termed natural cytotoxicity receptors (NCRs), consisting of NKp30 (Pende et al 1999) , NKp44 (Vitale et al 1998; Cantoni et al 1999) , and NKp46 (Pessino et al 1998) have been identified. Although NKp30 and NKp46 are constitutively expressed by almost all peripheral blood NK cells, the ligands regulating their expression and activatory function have not been defined yet.
By binding assays, an involvement of the C-type lectin receptor CD94 in the interaction of NK cells with Hsp70, the major stress-inducible member of the Hsp70 group could be demonstrated (Gross et al 2003) . Tumor cells expressing the C terminal-localized Hsp70 sequence ''TKDNNLLGRFELSG'' (TKD, aa [450] [451] [452] [453] [454] [455] [456] [457] [458] [459] [460] [461] [462] [463] ) on their cell surface are preferentially recognized and lysed by NK cells (Multhoff et al 1999) . Hsp70-protein and Hsp70-peptide TKD, both induce proliferative and cytolytic activity in NK cells (Multhoff et al 1999; . Concomitantly, the expression of the C-type lectin receptor CD94 and the neuronal adhesion-molecule CD56 was found to be upregulated on CD3-negative NK cells (Multhoff et al 1999; Moser et al 2002) . Other NK cell-specific receptors of the KIR family remained unaffected (Multhoff et al 1999) . Because it is known that the cell surface density of CD56 (Cooper et al 2001) and CD94 (Voss et al 1998; Jacobs et al 2001; Lian et al 2002; Gunturi et al 2003) are associated with the cytolytic function, we aimed to study changes in the mean fluorescence intensity (mfi) of these 2 markers in CD94-positive NK cell lines in response to Hsp70-peptide TKD. These data were compared with the cytolytic capacity against classical MHC class I-negative NK target cells (K562) and MHC class I-positive but Hsp70-positive (Cxϩ) or Hsp70-negative (CxϪ) tumor target cells.
MATERIALS AND METHODS

Tumor cell lines
The myelogenous cell line K562 was purchased from American Type Culture Collection (CCL 243, Rockville, MD, USA) and cultured in Roswell Park Memorial Institute-1640 medium (Gibco, Eggenstein, Germany) supplemented with heat-inactivated 10% fetal calf serum (FCS), 1 mM sodium pyruvate, 2 mM L-glutamine, 1% penicillin-streptomycin (all supplements purchased from Life Technologies, Rockville, MD, USA) at 37ЊC and 5% CO 2 .
The colon carcinoma sublines Cxϩ (Hsp70 membranepositive) and CxϪ (Hsp70 membrane-negative) derived by cell sorting (Multhoff et al 1997) from Cx2 colon carcinoma cells (Tumorzentrum Heidelberg, Heidelberg, Germany) differ with respect to their capacity to express Hsp70 on the plasma membrane. Cells were kept in culture under exponential growth conditions by regular cell passages. Every 3 days, cells were transferred after shortterm (maximum, 1 minute) trypsinization using trypsin and ethylenediamine-tetraacetic acid solution (Gibco), and 0.5 ϫ 10 6 cells were seeded in 5 mL fresh medium in T25 culture flasks.
In the cytotoxicity assay, K562 cells were used as a classical NK target, whereas Cxϩ and CxϪ cells were applied as MHC class I-positive tumor target cells.
NK cell lines
The human NK lymphoma cell line, NK-92 (Gong et al 1994) (ACC 488, DSMZ, Heidelberg, Germany) , was grown in RPMI-1640 medium with 20% heat-inactivated FCS, 1 mM sodium pyruvate, 2 mM L-glutamine, 1% penicillin-streptomycin, and 100 IU/mL IL-2; doubling time was 40 to 50 hours at cell densities ranging from 0.2 to 0.6 ϫ 10 6 cells/mL. NKL cell line (Robertson et al 1996) was cultured in RPMI-1640 medium with 10% heat-inactivated FCS, 1 mM sodium pyruvate, 2 mM L-glutamine, 1% penicillin-streptomycin, and 100 IU/mL IL-2; doubling time was 40 hours at cell densities ranging from 0.5 to 1 ϫ 10 6 cells/mL. The IL-2 independent growing NK cell line YT (Yodoi et al 1985) (ACC 434, DSMZ) was cultivated in RPMI-1640 medium with 10% heat-inactivated FCS, 1 mM sodium-pyruvate, 2 mM L-glutamine, 1% penicillin-streptomycin; doubling time was 50 to 60 hours at a constant low cell density of 0.1 ϫ 10 6 cells/mL.
Cytokine-induced killer cells
PBMNCs were isolated from buffy coats of healthy human volunteers by Ficoll separation followed by monocyte depletion. Peripheral blood lymphocytes were grown in RPMI-1640 medium with 10% heat-inactivated FCS, 25 mM Hepes (Invitrogen GmbH, Karlsruhe, Germany), 2 mM L-glutamine, 1% penicillin-streptomycin, and 50 M 2-mercaptoethanol. A quantity of 1,000 IU/mL of human recombinant interferon-␥ (Imukin, Roche Diagnostics GmbH, Mannheim, Germany) was added on day 0. After a 24-hours incubation period, CD3 monoclonal antibody (mAb, Ortho Biotech, Neuss, Germany), 50 ng/mL (38.1; P. Martin, University of Washington, Seattle, WA, USA), 300 IU/mL IL-2 (Proleukin, Chiron Behring GmbH, Marburg, Germany), and 100 IU/mL rIL-1␤ (Roche Diagnostics GmbH) were added. Cells were incubated at 37ЊC and 5% CO 2 and subcultured every 3 days in fresh medium at a cell density of 0.4 ϫ 10 6 cells/mL (SchmidtWolf et al 1991 (SchmidtWolf et al , 1997 .
CD94-positive NK cells
PBMNCs were separated by positive selection using biotinylated CD94 mAb (HP3-D9, Ancell Immunology Research Products, Bayport, MN, USA) and a standard Miltenyi biotin separation method (Miltenyi, Bergisch Gladbach, Germany). Briefly, 100 ϫ 10 6 cells/mL were incubated with 5 g biotin-conjugated CD94 mAb for 30 minutes at 4ЊC. After extensive washing with bovine serum albumin containing magnetic cell-sorting buffer (MACS-buffer, Miltenyi), cells were incubated with antibiotin beads for 15 minutes at 4ЊC under gentle shaking. After washing, CD94-positive cells were separated using a LS/VS column (Miltenyi).
Sorted cells were incubated for 4 days in RPMI-1640 medium with 10% heat-inactivated FCS, 1 mM sodium pyruvate, 2 mM L-glutamine, 1% penicillin-streptomycin, 100 IU/mL IL-2, and 2 g/mL Hsp70-peptide TKD (TKDNNLLGRFELSG, purity Ͼ96%; Bachem, Bubendorf, Switzerland) at 37ЊC. As a control, CD94-sorted NK cells were also incubated with the mutated peptide LKD (LKDNNLLGRFELSG, purity Ͼ96%; Bachem) under identical culture conditions. In long-term incubation experiments CD94-sorted NK cells were cultivated in fresh medium containing TKD (2 g/mL) plus low-dose IL-2 (100 IU/mL) weekly for 5 weeks.
CD3-positive T cells (CD3)
CD3-positive T cells were separated by positive selection from PBMNC using the CD3-separation kit (Miltenyi) according to a protocol described above. Sorted cells were incubated for 4 days in RPMI-1640 medium with 10% heat-inactivated FCS, 1 mM sodium pyruvate, 2 mM L-glutamine, 1% penicillin-streptomycin, 100 IU/mL IL-2, and 2 g/mL Hsp70-peptide TKD (Bachem) at 37ЊC.
Treatment
Exponentially growing tumor cells were either heat shocked at a temperature of 42ЊC for 1 hour, followed by a recovery period of 12 hours or treated with 1 M paclitaxel (Taxol-100, Bristol Arzneimittel, Munich, Germany) for 2 hours also followed by a recovery period of 12 hours. Previously published viability assays revealed that both treatment conditions were nonlethal for the tumor cells (Multhoff et al 1997; Gehrmann et al 2002) . After treatment, cells were analyzed with respect to their MHC class-I, class-II, and Hsp70 membrane expression by flow cytometry.
Flow cytometry
The following mouse fluorescein-conjugated mAb, were used for phenotypic characterization of effector and tar- 
Cell-mediated lympholysis assay
The cytolytic activity of primary effector cells and NK cell lines was monitored in a standard 51 Cr cytotoxicity assay ( 6 cells) were incubated for 15 minutes with 5 g/mL Hsp70-specific mAb (cmHsp70.1) after labeling and then used in the cytotoxicity assay without further washing. After a 4-hours incubation period, supernatants were collected and the radioactivity was quantified on a ␥-counter (Canberra Packard Instruments, Dreieich, Germany). Spontaneous release was determined using the supernatants of target cells that had not been coincubated with effector cells. Maximum release was determined in the suspensions of 51 Cr-labeled target cells. Specific lysis (%) was calculated according to the following equation: (experimental release Ϫ spontaneous release)/(maximum release Ϫ spontaneous release) ϫ 100. The percentage of spontaneous release in all experiments was always less than 20% for each target cell line.
RESULTS AND DISCUSSION
Separation of CD94-positive NK cells and CD3-positive T cells
We have shown previously that the C-type lectin receptor CD94 is involved in the interaction of NK cells with Hsp70, the major stress-inducible member of the Hsp70 family (Gross et al 2003) . Tumor cells expressing the Hsp70 epitope ''TKDNNLLGRFELSG'' on their cell surface are recognized and lysed by CD3-negative, CD94-positive NK cells (Multhoff et al 1999) . Incubation of primary human NK cells with Hsp70-peptide TKD plus low-dose IL-2 for 4 days results in an enhanced cytolytic activity against Hsp70-positive tumor cells (Multhoff et al 2001) . Concomitantly, the percentage of CD94-and CD56-positive cells increased. Other NK cell markers including CD16 and KIRs (CD158a/b; CD158e1/e2; CD158k) remained unaffected. IL-2 alone increases the expression of CD94 and CD56 marginally, indicating that TKD might have a synergistic effect on the upregulation of these NK cell-specific markers (Multhoff et al 1999) . In the present study, modulations in the protein density of CD56 and CD94 were compared in CD94-sorted, primary NK cells, and NK cell lines before and after stimulation with TKD. Concomitantly, the cytolytic capacity against the classical MHC class I-negative NK target cells (K562) and the MHC class I-positive, Hsp70 membrane-positive (Cxϩ) and membrane-negative (CxϪ) tumor cells was tested.
In the first set of experiments, CD94-positive NK cells were separated from PBMNCs of 8 healthy human volunteers by magnetic activated cell sorting (MACS). As a negative control, CD3-positive T cells were selected from 3 healthy human donors. Both positively enriched cell populations were cultured separately in the presence of low-dose IL-2 (100 IU/mL) and Hsp70-peptide TKD (2 g/mL). The concentration of the supplements was identified as the optimal activating dose for human NK cells in kinetical studies (Multhoff et al 1999) . The cell surface expression pattern of CD56, CD94, CD3, and CD16/56 in unstimulated PBMNC is illustrated in Fig. 1A . Freshly isolated cells were not phenotyped for CD94 and CD3 because antibody-coupled beads were still bound to the cell surface (data not shown). On day 4, after separation and stimulation a flow-cytometric analysis was performed. One representative result of the multiparameter flow cytometric analysis is illustrated in Fig. 1B , C. The mean percentages of positively stained cells Ϯ standard deviation of all experiments are summarized and given on the right hand side of each individual graph. After positive selection for CD94 and stimulation with TKD, 63 Ϯ 12% of the cells were found to be double positive for CD94 and CD56; 22 Ϯ 9% were positive for CD94, only (upper panel). A minor part of cells (2 to 3 Ϯ 3%) was found to be CD94-and CD3-negative. Because CD94 separation was not complete (purity Ͼ85%), on day 4 after stimulation, between 12% and 29% contaminating CD3-positive T cells were detected. With respect to the NK cell marker CD16/56 and the T cell marker CD3 this cell population contained 54% NK cells and 16% T cells (lower panel). A positive selection using a CD3-specific antibody followed by identical stimulation with TKD re- After long-term stimulation, the CD94/CD56-positive phenotype remained stable. Cells were incubated in fresh medium supplemented with TKD plus low-dose IL-2 once a week. Figure 2 shows representative dot-blot profiles of the CD94/CD56 staining of CD94-enriched NK cells on days 14, 21, 28, and 35. Although the percentages of CD94/CD56-positive cells remained constant, the mfi decreased during long-term culture (data not shown). The number of CD3-positive T cells did not increase; indicating that even repeated stimulation rounds with IL-2 plus TKD does not favor T cell growth. From these results, we conclude that it is possible to keep CD94/CD56-positive NK cells in culture for several weeks.
A comparison of the protein density, as determined by the mfi, of unstimulated and TKD-stimulated CD94-sorted NK cells and NK cell lines NK-92, NKL, and YT revealed that a significant increase in CD94 and CD56 expression was detected only with primary NK cells, within 4 days of stimulation (Table 1) .
Comparative phenotypic characterization of the cellsurface markers CD94 and CD56 on primary NK, CIK, and T cells and on NK cell lines NK-92, NKL, and YT
In addition to the CD94 and CD56 expression, differences in the expression pattern of newly defined NCRs, NKp30 and NKp46 were tested in CD94-enriched NK cells, CD3-enriched T cells, and in NK cell lines NK-92, NKL, and YT after treatment with IL-2 plus TKD. In contrast to primary human NK cells, neither NK cell lines nor T cells showed any difference in their CD94, CD56, or NCR expression pattern after TKD stimulation. The percentages of positively stained cells and mfi values of all markers derived from 3 to 8 independent experiments after stimulation are summarized in Table 2 . After cell sorting and TKD stimulation, 85% of the primary NK cells were positive for the C-type lectin receptor CD94; 63% of these cells also expressed the neuronal adhesion molecule CD56. NKp30 and NKp46 was found on 58% and 75% of the CD94-sorted cells, respectively, and on the NK lines NK-92 (29% and 62%) and NKL (78% and 77%) at variable percentages. These markers did not differ before and after stimulation with TKD. YT cells were negative for NKp30 (0%) but strongly positive for NKp46 (98%). CD3-sorted T cells were negative for all tested markers. Both NK cell lines, NK-92 and NKL, were found to express CD94 (99%). However, coexpression of CD56 was determined only on NK-92 cells (99%). In contrast, only a small subpopulation of 15% of the NKL cells did express CD56. As shown previously, the percentage of CD94-positive cells varied on YT cells between 13% and 52%, depending on the number of cells in culture; a negative correlation was consistently found with increasing cell densities (Gross et al 2003) . With the culture conditions tested here, 37% to 54% of the YT cells were positive for CD94; CD56 was almost not detectable. CIK cells were also analyzed with respect to their CD94 and CD56 expression pattern. Because CIK cells are a heterogeneous cell population consisting of a mixture of T and NK cells, the percentages for CD94 and CD56 varied from 18% to 54% and from 29% to 67%, respectively. Because of this high variability, standard deviations were not provided for CIK cells.
With respect to the mfi, again striking differences were found between primary NK cells and NK cell lines. Only primary NK cells reacted on TKD stimulation with a significantly upregulated mfi of CD94 from 156 to 416, and of CD56 from 114 to 393, between day 0 and day 4 ( Table  1) In summary, although the percentages of CD94-positive cells were comparably high in primary NK cells and NK cell lines NK-92 and NKL, striking differences were recorded with respect to the cell surface density of this receptor. Furthermore, only primary NK cells reacted with a significant upregulation in the cell surface density of CD94 after stimulation with TKD. All other tested markers remained unaltered. Similar results were seen for the neuronal adhesion molecule CD56. To distinguish the different NK cell types on the basis of their CD94/ CD56 receptor density, the mfi values were marked in Figure 3 with ϩ and Ϫ symbols as follows: mfi Ͼ 300, ϩϩϩ; mfi 150-300, ϩϩ; mfi 10-150, ϩ; mfi Ͻ 10, Ϫ.
Association of the cell surface intensity of CD94/CD56 with Hsp70 reactivity
The cytolytic response of the different effector cells, prestimulated with TKD, was tested in a 4-hours cytotoxicity assay using the myeloid cell line K562 and the colon carcinoma sublines Cxϩ and CxϪ as target cells. A phenotypic characterization of the tumor cell lines is summarized in Table 3 . Only Cxϩ and CxϪ colon carcinoma cells were found to be positive for MHC class-I molecules; the classical NK target cell line K562 was MHC class I-negative. With respect to the missing-self theory (Ljunggren and Kärre 1990) , K562 cells are lysed because of a deficient MHC class-I expression associated with a lack of inhibitory signals for KIRs. On the other hand about 50% of the K562 cells do express Hsp70 on their cell surface and thus provide a recognition signal for the activating form of the C-type lectin receptor CD94. Therefore, we assumed that recognition of K562 cells is mediated by at least 2 receptor mechanisms: inactivating of inhibitory KIRs due to the missing MHC class-I expression and activating of the C-type lectin receptor due to the Hsp70 membrane expression. Because it is known that Cxϩ and CxϪ exhibit an identical MHC class-I and class-II expression pattern but differ significantly with respect to their Hsp70 membrane expression (Multhoff et al 1997) , an involvement of KIR could be ruled out for the Hsp70 reactivity. In addition to MHC class-I, class-II, and Hsp70, the expression of several adhesion molecules including CD54 (intracellular adhesion molecule (ICAM)), CD106 (vascular adhesion molecule (VCAM)), CD57 and CD56 (neuronal adhesion molecule (NCAM)) 
Cells were stained with the following fluorescein-conjugated antibodies: CD3 fluorescein isothiocyanate, CD16/56 phycoerythris (PE), CD56 FITC, CD94 PE, NKp30 PE, and NKp46 PE. a mfi of CD94/CD56-positive cells. b Heterogeneous cell population, a range or a median value is provided. were determined on the target cell lines. K562, Cxϩ and CxϪ tumor cells were strongly positive for CD54. With respect to the adhesion molecules CD106, CD57, and CD56, only Cxϩ and CxϪ tumor cells showed a comparable but weak expression; K562 cells were negative for these markers. Also, the multidrug resistance gene product MDR-1 was comparably expressed on Cxϩ and CxϪ tumor cells but not on K562 cells. With respect to the expression of the stress-inducible MHC-related molecule MICA, only K562 cells were found to be positive. HLA-E 
Mean values of at least 3 different experiments are shown. Table 4 . CxϪ tumor cells exhibited an upregulated Hsp70 expression after P treatment that correlates with an increased sensitivity to lysis. Nonlethal heat shock neither increases Hsp70 membrane expression nor lysis of CxϪ cells. The spontaneous release for each target cell was less than 20%. Effector to target cell ratios were 10:1, 5:1, and 2:1. Because Cxϩ and CxϪ tumor cells differ only with respect to the Hsp70 membrane expression, we speculated that differences in lysis mediated by TKD-stimulated CD94-positive primary NK cells is due to Hsp70 that appears to function as an activating signal. CD94 has been found to be involved in the interaction of NK cells with Hsp70 protein (Gross et al 2003) . Although all NK cell lines were positive for CD94, they showed different cytotoxicity against Hsp70-positive tumor target cells. Therefore, we suggest that the differences in cell kill might be associated with the cell surface density of CD94. Cells were stained with fluorescein isothiocyanate or phycoerythrin-conjugated antibodies. Mean values of at least 3 different experiments are shown. Untreated and treated cells were used as target cells for CD94-sorted natural killer cells in cytotoxicity assays.
Fig 6.
Comparative cytolytic activity of CD94 high (ϩϩϩ) and CD94 low (ϩϩ) expressing natural killer (NK) cells. Peripheral blood mononuclear cells were separated in CD94 high (ϩϩϩ) and CD94 low (ϩϩ) expressing NK cells by flow cytometry cell sorting. Both subpopulations were stimulated with low dose interleukin-2 (100 IU/mL) and TKD (2 g/mL) for 4 days and used as effector cells in a 4-hours 51 Cr cytotoxicity assay. Major histocompatibility complex class I-and Hsp70-positive tumor cells were used as target cells. The spontaneous release for each target cell was less than 20%. Effector to target cell ratios were only 2:1, 1:1, and 0.5:1.
Cells with high (ϩϩϩ, mfi Ͼ 300) expression levels of this receptor showed an increased kill of Hsp70-positive tumor cells. NK cells with moderate (ϩϩ, mfi 150-300) or low (ϩ, mfi Ͻ 10) expression levels in this marker did not show any Hsp70-specific kill, indicating an essential role of the protein density of CD94 for Hsp70 reactivity. Study of Michaelsson (2002) revealed that HLA-E, presenting leader peptides from Hsp60, results in increased sensitivity to lysis mediated by NK cells due to a loss of recognition by CD94/NKG2A inhibitory receptors. Because Cxϩ and CxϪ tumor cells both exhibited a comparable but very low HLA-E surface expression pattern and K562 cells completely lack expression of HLA-E, an involvement of HLA-E in the recognition by CD94-positive, primary NK cells was excluded. Similar to CD94, CD56 was upregulated in CD94-sorted, primary NK cells after stimulation with TKD. Because CD56 mediates homophilic cell adhesion, we speculated about a role of CD56 in the cytolytic response against Hsp70-positive tumor target cells. However, Cxϩ and CxϪ cells revealed identical CD56 expression levels (Multhoff et al 1997) , whereas K562 cells lack CD56 expression (Table 3) . In contrast to this finding, Cxϩ and K562 cells, but not CxϪ cells, were lysed by primary TKD-stimulated NK cells. Therefore, the involvement of CD56 in the cytolytic mechanism of Hsp70-positive tumor target cells remained to be elucidated. Concomitant with the finding that stimulation of NK cell lines NK-92, NKL, and YT with TKD did not increase the cell surface expression of CD94 and CD56, the cytolytic activity against Hsp70 membrane-positive tumor cells was also not enhanced.
To prove that indeed Hsp70 provides the target structure for CD94-sorted, TKD-stimulated NK cells, antibody blocking studies were performed. As illustrated in Figure  4 , the increased lysis of Cxϩ tumor cells could be reduced to the degree of CxϪ cell lysis by Hsp70-specific antibody. In contrast, lysis of CxϪ cells remained unaffected after antibody incubation (data not shown). These findings were further supported by the fact that a paclitaxel-induced increase in membrane-bound Hsp70, especially on CxϪ cells, correlated with an increased sensitivity toward lysis mediated by NK cells (Fig. 5) . The Hsp70 phenotype together with the MHC class-I and II expression in Cxϩ and CxϪ tumor cells before and after nonlethal heat shock (42ЊC) or treatment with a nonlethal concentration of paclitaxel (1 M) are summarized in Table 4. Heat was unable to induce an increased membrane expression of Hsp70 and thus lysis of CxϪ cells remained unaltered (Fig. 5, left graph) . However, after paclitaxel treatment (Fig. 5, right graph) , Hsp70 expression was significantly upregulated in CxϪ tumor cells. Concomitantly the percentage-specific lysis drastically increased. Because upregulation of membrane-bound Hsp70 in Cxϩ cells was only marginal, no upregulated cytotoxicity of Cxϩ cells was observed (data not shown). In summary, these findings clearly indicate that Hsp70 provides the target structure for TKD-stimulated, CD94-positive primary NK cells.
In an effort to further elucidate the role of CD94 in the cytolytic activity, more detailed additional cell-sorting experiments were performed. As demonstrated in Figure 6 , primary NK cells consist of 2 subgroups that differ with respect to their CD94 mfi cell surface expression pattern. By cell sorting through CD94, 2 subpopulations with CD94 high (ϩϩϩ, mfi Ͼ300), and CD94 intermediate (ϩϩ, mfi 150-300) mfi were generated. Both subpopulations were incubated separately with low-dose IL-2 and TKD for 4 days. A representative flow cytometric profile of both populations is illustrated in the middle panel of Figure 6 . The CD94 high population was also strongly positive for CD56, whereas the CD94 intermediate population was weakly positive for CD56. Both subpopulations were tested as effector cells in a 4-hours cytotoxicity assay using MHC class-I and Hsp70-positive tumor cells as targets. As illustrated in Figure 6 , the CD94 high population showed an increased killing activity of Hsp70-positive tumor cells compared with the CD94 intermediate population.
Finally, the role of the 14 amino acid peptide TKD, as a naturally occurring sequence of the Hsp70-protein, in the stimulation of the NK cell activity and CD94 expression was analyzed in comparison with a mutated 14-mer peptide that exhibits 1 amino acid sequence exchange at position 1 (T-L). Both peptides were tested under identical conditions (2 g/mL for 4 days) with respect to their immunostimulatory efficacy on CD94-sorted, primary NK cells. Interestingly, only TKD but not LKD in combination with low-dose IL-2 (100 IU/mL) was able to induce Hsp70 reactivity toward Cxϩ tumor cells. Furthermore, an increase in CD94 mfi was also only observed with TKD-stimulated NK cells (Fig. 7) . Taken together, these findings support our hypothesis that indeed the mfi of the CD94 expression is a relevant marker for the Hsp70 reactivity.
